Lenington Rachel - Insider Non-Derivative Transactions at Athira Pharma, Inc. (ATHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 5, 2024, Lenington Rachel's relationship to Athira Pharma, Inc. (ATHA) is Officer (COO and CDO), and currently has 20,870 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATHA insiders.
Data Source: SEC.
Lenington Rachel - Insider Non-Derivative Transactions of ATHA Common Stock
Lenington Rachel - Insider Non-Derivative Transactions at ATHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 6, 2024 | Sell -- (Common Stock) | 2525 | 0.57 | 20870 |
| Sep 4, 2024 | Acquisition -- (Common Stock) | 10000 | 0 | 23395 |
| Jan 6, 2024 | Sell -- (Common Stock) | 2412 | 2.91 | 13395 |
| Jan 5, 2024 | Acquisition -- (Common Stock) | 10000 | 0 | 15807 |